ICER publishes second annual assessment of barriers to fair access within US commercial insurance prescription drug coverage

ICER

17 January 2023 - During ICER’s assessment, five payers revised policies for 11 medicines in ways that bring coverage into concordance with fair access criteria, demonstrating that assessment and greater transparency may lead to positive change.

The ICER today published its second annual “Barriers to Fair Access” assessment of prescription drug coverage policies.

Read ICER Announcement 

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing